September 13th - 30th, 2021
Meet 15 Korean Bio & Pharma Leaders Tackling Covid-19 on the Frontline
Ensure your browser is updated to the latest version. Use the latest internet explorer to optimize your view.
In May of 2021, the U.S. and Korea decided to establish 'KORUS Global Vaccine Partnership', in a summit meeting between U.S. President Joe Biden and Rep. of Korea President Moon Jae-in.
Both countries have recognized the suffering COVID-19 has caused all over the world and therefore decided to share a multilateral cooperation to bring an early end to the COVID-19 pandemic. This partnership was formed to supply more COVID-19 vaccines globally and to combine U.S. vaccine technology and Korea's production capacity.
Ministry of Trade, Industry and Energy & KOTRA are organizing 'U.S.-Korea Global Vaccine Partnership' to showcase 15 renowned, cutting-edge Korean Bio/Pharmaceutical companies. We hope this event will not only expand the production of vaccines that have been demonstrated safe and effective, but also provide a positive and stable vaccine supply to the world.
If you are looking for or in need of partners in the categories below, please click HERE to request a 1:1 virtual meeting. Our 15 prominent companies are waiting for successful collaborations.
SCHEDULE 1:1 Virtual Meeting
<R&D Cooperation>
- New drug development based on small molecule drugs on GI, Immune and Oncology
- Developing COVID-19 vaccine and CAR-T drug with protein and cell production GMP infrastructure
Prestige BioPharma
- State of the art vaccine manufacturing center with 104,000ℓ of production capacity.
- Single-use Bioreactor system supports large-scale vaccine production with minimal risk of cross contamination.
Samyang Holdings
- Promotes the R&D and commercialization of sustained release injectables through open innovation using drug delivery technology (DDS).
- Develop a COVID-19 vaccine and is researching an mRNA vaccine using stability enhanced nanoshell (mSENS).
<Raw Material Supply>
- Vial and ampoule containers with outstanding stability and quality.
- With over 50 years of experience, products are sold to over 100 domestic customers in Korea and are exported to the world.
- Polyethylene 2D, 3D Singl-Use bag with 0.325 mm Film thickness
- 50, 100, 200, 500, 1000 Liter Mixing System with IP65
Enzychem Lifesciences
- Offers lipid production and supply, LNP formulation with technical transfer.
- mRNA CMO production available Jan 2022.
- Produces approximately 200 highest purity enzymes, consisting of 130 restriction endonucleases, 20 DNA polymerases, and 50 modifying enzymes.
- Offers various high-quality experiment kits using our own enzymes.
-The world’s largest supplier of Thymidine/Zidovudine to GSK and Sofosbuvir to Gilead.
-Experts in nucleotide based pharmaceuticals, providing key intermediates or APIs from nucleotide tooligonucleotide.
- Produces the specialty lipid compounds needed to deliver mRNA vaccines.
- Supplies cationic lipids (SM-102, ALC-0315) and phospholipids(DSPC).
Contact Us
KOTRA staff will contact you to prepare and arrange 1:1 virtual meetings with the selected potential partners
Minimum 3 availabilities required
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
SCHEDULE 1:1 Virtual Meeting
Sponsored by
"This material is distributed by KOTRA on behalf of the Korea Trade-Investment Promotion Agency.
Additional Information is available at the Department of Justice, Washington, DC."